Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07771049Phase 2Active, not recruiting
A Phase 2 trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine, ketamine, magnesium sulfate, dexamethasone in postoperative pain, sponsored by Hospital Universitari i Politècnic La Fe. Started Mar 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07771049.